There are no proven peptides for PTSD. Oxytocin is the only peptide tested in several PTSD trials, and the largest one was negative: in a 180-veteran VA trial, adding oxytocin nasal spray to prolonged exposure therapy did not improve PTSD symptoms compared with placebo.[4] Oxytocin given soon after trauma also failed to prevent PTSD overall.[6] No other peptide, including Selank, has published PTSD trials. Proven trauma-focused therapies and approved medicines remain the standard.[3]
This guide grades the evidence. For the broader topic, see our nootropic peptides hub.
Evidence at a glance
| Peptide or treatment | Evidence level | What was shown | FDA status | Our profile |
|---|---|---|---|---|
| Trauma-focused therapy (PE, CPT, EMDR) | Human RCTs | Recommended first-line in VA/DoD guideline[3] | Not drugs | n/a |
| Sertraline, paroxetine, venlafaxine | Human RCTs | Recommended medicines in VA/DoD guideline[3] | Approved antidepressants (not peptides) | n/a |
| Oxytocin with prolonged exposure | Human RCTs | No added benefit in 180-veteran trial[4] | Approved only as an injection for labor and postpartum bleeding[13] | Oxytocin |
| Oxytocin for prevention after trauma | Human RCTs | No overall effect in 120 ED patients[6] | Not approved for this use | Oxytocin |
| Selank, DSIP, other research peptides | No evidence, marketing only | No PTSD trials found | Not approved | Selank, DSIP |
Start with what works
The 2023 VA and Department of Defense guideline, built from a systematic review of the evidence, recommends specific manualized psychotherapies over medicine: prolonged exposure (PE), cognitive processing therapy (CPT) or eye movement desensitization and reprocessing (EMDR). When medicine is used, it recommends paroxetine, sertraline or venlafaxine. It also supports therapy by secure video when validated, and recommends against benzodiazepines, cannabis and cannabis-derived products.[3]
These therapies take weeks and can be hard work, which is one reason researchers have looked for a drug that could make them work faster or better. Oxytocin has been the main peptide candidate.
Why oxytocin was tried
Oxytocin is a hormone involved in bonding, trust and stress responses. In lab studies it can dampen fear responses and support “extinction learning,” the process by which exposure therapy is thought to work. The idea was to give a nasal dose shortly before each therapy session.[5] A 2020 systematic review of 14 studies found the results mixed, with small samples and different outcomes across studies, though oxytocin appeared safe.[8]
Oxytocin with therapy: the trials
- Pilot trial (2018): 17 people took 40 units of nasal oxytocin or placebo 45 minutes before each weekly PE session. The oxytocin group had lower PTSD and depression scores and better working alliance, but none of the differences were statistically significant.[5]
- VA multisite trial (results posted March 2026): 180 veterans received 10 weekly 90-minute PE sessions with 40 units of oxytocin or an identical placebo 30 minutes before each session. On the clinician-rated PTSD scale (CAPS-5), symptoms fell by an average of about 10 points with oxytocin and 12 points with placebo. On the self-report PTSD checklist, they fell by about 19 points with oxytocin and 25 with placebo.[4] Both groups improved, showing PE itself worked, but oxytocin added nothing.
- Couples therapy pilot (2023): 10 veterans used oxytocin before brief couples therapy for PTSD. There was no placebo group, so the large improvements reported cannot be credited to oxytocin.[9]
Oxytocin to prevent PTSD
In a Dutch trial, 120 emergency department patients with significant distress after trauma, mostly accidents, took nasal oxytocin or placebo twice daily for 8 days, starting within 12 days of the event. PTSD symptoms did not differ between groups at 1.5 months or later. People with high early symptoms appeared to do better on oxytocin in a secondary analysis, which needs confirmation.[6] A 2024 Cochrane review of early drug treatments, including oxytocin, judged the evidence uncertain and called for larger trials.[7]
Why oxytocin may not have helped
Several explanations are possible. Prolonged exposure therapy already works well for many people, as the large symptom drops in both groups of the VA trial showed, which leaves less room for an add-on to make a difference.[4] The earlier pilot was too small to separate a real effect from chance.[5] Studies of oxytocin in PTSD have also used different doses, timings and outcomes, which makes results hard to compare.[8] These are possibilities, not proven explanations, and they leave oxytocin as a research question rather than a treatment.
Other peptides marketed for trauma and stress
Online sellers promote Selank, DSIP and other “calming” peptides for stress and trauma. We found no PTSD trials for any of them. Selank’s small human studies were in anxiety, and DSIP’s were in insomnia. See best peptides for anxiety for what those studies found.
What’s next
- Couples therapy trial: a VA phase 2 trial plans to enroll 240 veterans to test oxytocin with brief couples therapy, with completion expected in 2028.[10]
- PTSD with alcohol use disorder: a 175-person trial testing oxytocin with integrated exposure-based treatment finished in 2026, with no results posted yet.[11]
Safety notes
Short-term nasal oxytocin at research doses of 18 to 40 units has had few side effects in controlled studies.[12] But no oxytocin nasal spray is approved in the US; the approved product is an injection used in childbirth.[13] Products sold online are not checked for purity or dose, and FDA lists several research peptides among compounding substances with safety concerns.[14] Selank and similar peptides have no PTSD safety data.
Questions to ask your clinician
- Am I getting a trauma-focused therapy such as PE, CPT or EMDR?
- Is my medicine one the guideline recommends, at the right dose?
- Are there clinical trials I could join?
For related reading, see peptides for depression, best peptides for anxiety, DSIP vs melatonin and Selank vs Semax.
